Trials / Unknown
UnknownNCT02469883
A Study of Sinotecean on Tolerance and Pharmacokinetics
A Phase I Study of Sinotecean on Tolerance and Pharmacokinetics
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is conducted to assess the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT), to evaluate the pharmacokinetics, safety and preliminary anti-tumor activity of Sinotecean.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sinotecean |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-08-01
- Completion
- 2016-12-01
- First posted
- 2015-06-12
- Last updated
- 2015-06-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02469883. Inclusion in this directory is not an endorsement.